Research
    Minghuang Hong
    Title Professor, Director of Clinical Trial Center
    Profile

    Dr. Hong received his M.D. from Sun Yat-Sen University of Medical Sciences (SUMS) in 1984, and worked for the department of design, measure, and evaluation (DME), SUMS. During 1987 to 1988, he finished a postgraduate training on medical decision in Case Western Reserve University, Cleveland, USA . Since 1991, Dr. Hong turned to department of NPC, Cancer Center, SUMS, as a lecturer, and took part in a series of the clinical investigations using the theory of DME. The development of new clinical staging system of NPC (1992 NPC staging), which was used widely later in China, was one of Dr. Hong contributions. The proposition of the idea of stratified multiple modality therapy of NPC according to different clinical stages was another project of Dr. Hong using the methods and viewpoints of DME.

    Dr. Hong was promoted to be an associate professor in 1994. The clinical trails of stratified comprehensive therapy of NPC in an ongoing project under the charge of Dr. Hong. His main interest is multiple modality combined therpay of NPC.

    Email
    Phone
    Research Interest(s)
    Education
    Publications
    Li Su
    Title Research fellow, Director of GCP Office
    Profile

    Since 1998, she has been working at Medical Oncology of Sun Yat-sen University Cancer Center and Good Clinical Practice (GCP) Center for New Anticancer Drugs. She is familiar with theories and techniques of molecular biology, capable of conducting experiment in cell biology, flow cytometry experiment and Western Blot; she has also mastered pharmacology experimental theories and techniques of pharmacology for anticancer drugs, and is able to inoculate tumor-bearing nude mice to test the anti-tumor efficacy of anticancer drugs. She has published more than 10 papers, and has led several research projects.

    What is more, she has mastered biopharmaceutical analysis of drugs, proficient in operating atomic absorption spectroscopy instrument, high-performance liquid chromatography instrument, ultraviolet–visible spectrophotometer, microplate reader, RT-PCR instrument, and etc. She is familiar with national guidelines for GCP for trials on pharmaceutical products, including those for pharmacokinetic experiment, capable of establishing pharmacokinetic analysis methods and determining drug concentration; she can write plans and reports for pharmacokinetic experiments in Phase I/II/III clinical trials, and conduct preliminary analysis on pharmacokinetic-pharmacodynamic relationship, and the interaction of drugs.

    Since 1998, she has led clinical pharmacokinetic study on several domestic and foreign Category I new drugs. Pharmacokinetic study of Phase I clinical trial of domestic drugs includes E10A (preparation for endostatin gene), ATV-TK/GCV, vinflunine, dicycloplatin, combretastatin, puquitinib mesylate, SM03 (CD22 monoclonal antibody), and fluorapacin; pharmacokinetic study of Phase I clinical trial of foreign drugs: ZD6474 and capxol; pharmacokinetic study of Phase III clinical trial: epothilone and etc.

    Email
    Phone
    Research Interest(s)
    Education
    Publications
    Sun Jian
    Title Research Associate
    Profile

    Prof. Sun Jian has been working in Sun Yat-sen University Cancer Center since 2001. From September 2012 to April 2013, he was engaged as an external reviewer of Center for Drug Evaluation (CDE) in China Food and Drug Administration (CFDA). Now he serves as team leader of Quality Control Team at the GCP Center (a qualified national institution for clinical trial of new drugs), engaged in clinical trials of new drugs, quality control of clinical trial of in-vitro diagnostic reagents and medical devices, and management of institution’s offices.

    Email
    Phone
    Research Interest(s)
    Education
    Publications
    Zhao Hong Yun
    Title Associate Professor and Associate Chief Physician
    Profile

    Employed as a medical doctor by Sun Yat-Sen University Cancer Center and worked in medical oncology department and clinical trial center from 2003 after master degree of oncology until now. Got PhD degree in Sun-Yat sen University Cancer Center in 2011, mastered the key techniques of ELISA, RT-PCR, IHC, Cell Culture etc. During MD & PhD studies and clinical works, received professional training of researches on anti-cancer new drugs, and acquired the certificate of clinical trial training awarded by VIENNA School of CLINICAL RESEARCH, which is highly accredited. Shortly studied in The Chinese University of Hong Kong - Prince of Wales Hospital for clinical trial design and implementation in 2003. Participated in over 20 Phase I to IV clinical trials domestic or international, including INFORM study which had been selected as one of the top ten clinical oncology progress in 2012.

    Email
    Phone
    Research Interest(s)
    Education
    Publications

Where are we | Contact us

Copyright:Sun Yat-sen University Cancer Center Designed by Wanhu.